Fintel reports that on October 31, 2025, Stifel maintained coverage of DXC Technology (NYSE:DXC) with a Hold recommendation.
Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.
TipRanks on MSN
DXC Technology Reports Q2 Fiscal 2026 Results
Dxc Technology Company ( ($DXC) ) has released its Q2 earnings. Here is a breakdown of the information Dxc Technology Company presented to its ...
Discover DXC Technology's Q2 2026 earnings insights, AI-driven strategy, and growth goals for SAP & SaaS revenue.
Medicare Part B data show that of the 20 CPT codes seeing the largest increase in payments from 2022 to 2024, all are for molecular- or sequencing-based tests.
Loeb, Affiliated Investigator Angela Parcesepe, Distinguished Professor Denis Nash, and colleagues from the CUNY Institute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback